Annual Report — Form 10-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 801K
2: EX-21.1 Subsidiaries List HTML 31K
3: EX-23.1 Consent of Expert or Counsel HTML 24K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 26K
14: R1 Document And Entity Information HTML 59K
15: R2 Consolidated Balance Sheets HTML 149K
16: R3 Consolidated Balance Sheets (Parentheticals) HTML 42K
17: R4 Consolidated Statements of Operations and HTML 91K
Comprehensive Loss
18: R5 Consolidated Statement of Stockholders? Equity HTML 75K
19: R6 Consolidated Statements of Cash Flows HTML 112K
20: R7 Nature of Operations and Management's Plans HTML 32K
21: R8 Significant Accounting Policies HTML 63K
22: R9 Inventory HTML 37K
23: R10 Deposits and Advances HTML 37K
24: R11 Intangible Assets HTML 52K
25: R12 Property, Plant and Equipment HTML 54K
26: R13 Investments in Non-Marketable Securities HTML 41K
27: R14 Claims and Advances HTML 37K
28: R15 Leases HTML 65K
29: R16 Accrued Liabilities and Others HTML 36K
30: R17 Loans and Other Liabilities HTML 38K
31: R18 Commitments and Contingency HTML 30K
32: R19 Securities HTML 33K
33: R20 Stock-Based Compensation HTML 63K
34: R21 Fair Value of Financial Instruments HTML 81K
35: R22 Income Taxes HTML 85K
36: R23 Revenue Recognition HTML 47K
37: R24 Segment Information HTML 109K
38: R25 Subsequent Events HTML 28K
39: R26 Accounting Policies, by Policy (Policies) HTML 118K
40: R27 Inventory (Tables) HTML 36K
41: R28 Deposits and Advances (Tables) HTML 37K
42: R29 Intangible Assets (Tables) HTML 53K
43: R30 Property, Plant and Equipment (Tables) HTML 54K
44: R31 Investments in Non-Marketable Securities (Tables) HTML 40K
45: R32 Claims and Advances (Tables) HTML 37K
46: R33 Leases (Tables) HTML 70K
47: R34 Accrued Liabilities and Others (Tables) HTML 36K
48: R35 Loans and Other Liabilities (Tables) HTML 33K
49: R36 Stock-Based Compensation (Tables) HTML 67K
50: R37 Fair Value of Financial Instruments (Tables) HTML 79K
51: R38 Income Taxes (Tables) HTML 86K
52: R39 Revenue Recognition (Tables) HTML 42K
53: R40 Segment Information (Tables) HTML 108K
54: R41 Significant Accounting Policies (Details) HTML 43K
55: R42 Inventory (Details) HTML 29K
56: R43 Inventory (Details) - Schedule of Inventory, HTML 33K
Current
57: R44 Deposits and Advances (Details) HTML 26K
58: R45 Deposits and Advances (Details) - Deferred Costs, HTML 36K
Capitalized, Prepaid, and Other Assets Disclosure
59: R46 Intangible Assets (Details) HTML 32K
60: R47 Intangible Assets (Details) - Schedule of HTML 46K
Intangible Assets And Goodwill
61: R48 Intangible Assets (Details) - Schedule of HTML 36K
Finite-Lived Intangible Assets, Future
Amortization Expense
62: R49 Property, Plant and Equipment (Details) HTML 27K
63: R50 Property, Plant and Equipment (Details) - HTML 61K
Property, Plant and Equipment
64: R51 Investments in Non-Marketable Securities (Details) HTML 32K
65: R52 Investments in Non-Marketable Securities (Details) HTML 35K
- Schedule of Investments
66: R53 Claims and Advances (Details) HTML 29K
67: R54 Claims and Advances (Details) - Schedule of Other HTML 33K
Assets, Noncurrent
68: R55 Leases (Details) HTML 34K
69: R56 Leases (Details) - Lease, Cost HTML 31K
70: R57 Leases (Details) - Lessee, Operating Lease, HTML 41K
Disclosure
71: R58 Leases (Details) - Lessee, Operating Lease, HTML 40K
Liability, Maturity
72: R59 Accrued Liabilities and Others (Details) HTML 29K
73: R60 Accrued Liabilities and Others (Details) - HTML 35K
Schedule of Accounts Payable and Accrued
Liabilities
74: R61 Loans and Other Liabilities (Details) HTML 59K
75: R62 Loans and Other Liabilities (Details) - Schedule HTML 28K
of Loans and Other Liabilities
76: R63 Commitments and Contingency (Details) HTML 30K
77: R64 Securities (Details) HTML 47K
78: R65 Stock-Based Compensation (Details) HTML 52K
79: R66 Stock-Based Compensation (Details) - Schedule of HTML 37K
Share-based Payment Award, Stock Options,
Valuation Assumptions
80: R67 Stock-Based Compensation (Details) - Nonvested HTML 44K
Restricted Stock Shares Activity
81: R68 Stock-Based Compensation (Details) - Share-based HTML 45K
Payment Arrangement, Option, Activity
82: R69 FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - HTML 48K
Schedule of Fair Value, Assets and Liabilities
Measured on Recurring Basis
83: R70 INCOME TAXES (Details) - Schedule of Effective HTML 46K
Income Tax Rate Reconciliation
84: R71 Income Taxes (Details) - Schedule of Components of HTML 38K
Income Tax Expense (Benefit)
85: R72 Income Taxes (Details) - Summary of Operating Loss HTML 67K
Carryforwards
86: R73 REVENUE RECOGNITION (Details) - Disaggregation of HTML 48K
Revenue
87: R74 Segment Information (Details) HTML 29K
88: R75 Segment Information (Details) - Revenue from HTML 40K
External Customers by Products and Services
89: R76 Segment Information (Details) - Revenue from HTML 43K
External Customers by Geographic Areas
90: R77 Segment Information (Details) - Schedule of HTML 54K
Revenue from External Customers and Long-Lived
Assets, by Geographical Areas
91: R78 Subsequent Events (Details) HTML 28K
93: XML IDEA XML File -- Filing Summary XML 173K
92: EXCEL IDEA Workbook of Financial Reports XLSX 105K
8: EX-101.INS XBRL Instance -- igc-20210331 XML 1.30M
10: EX-101.CAL XBRL Calculations -- igc-20210331_cal XML 154K
11: EX-101.DEF XBRL Definitions -- igc-20210331_def XML 676K
12: EX-101.LAB XBRL Labels -- igc-20210331_lab XML 1.22M
13: EX-101.PRE XBRL Presentations -- igc-20210331_pre XML 676K
9: EX-101.SCH XBRL Schema -- igc-20210331 XSD 187K
94: ZIP XBRL Zipped Folder -- 0001185185-21-000802-xbrl Zip 165K
‘EXCEL’ — IDEA Workbook of Financial Reports
This is an IDEA Workbook.
1 Subsequent Filing that References this Filing
8 Previous Filings that this Filing References
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent
1/22/21 IGC Pharma, Inc. POS AM 4:206K Federal Filings, LLC/FA
1/13/21 IGC Pharma, Inc. 8-K:1,9 1/13/21 3:285K Federal Filings, LLC/FA
7/13/20 IGC Pharma, Inc. 10-K 3/31/20 106:6.9M Federal Filings, LLC/FA
6/14/19 IGC Pharma, Inc. 10-K 3/31/19 92:5.5M Federal Filings, LLC/FA
10/02/18 IGC Pharma, Inc. 424B5 1:432K Federal Filings, LLC/FA
10/10/17 IGC Pharma, Inc. DEF 14A 11/08/17 2:651K Federal Filings, LLC/FA
6/12/17 IGC Pharma, Inc. 8-K:8,9 6/12/17 2:35K Federal Filings, LLC/FA
8/06/12 India Globalization Capital, Inc. 8-K:5,9 8/01/12 2:63K Federal Filings, LLC/FA
|
↑Top
Filing Submission 0001185185-21-000802 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Thu., May 2, 12:17:31.1am ET 
